Janus Henderson Group PLC Invests $896,000 in Electromed, Inc. (NYSE:ELMD)

Janus Henderson Group PLC bought a new position in shares of Electromed, Inc. (NYSE:ELMD - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 30,334 shares of the company's stock, valued at approximately $896,000. Janus Henderson Group PLC owned 0.36% of Electromed as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently bought and sold shares of the company. Russell Investments Group Ltd. acquired a new stake in shares of Electromed in the 4th quarter valued at about $37,000. IFP Advisors Inc acquired a new stake in Electromed in the 4th quarter valued at approximately $59,000. Quantbot Technologies LP bought a new stake in Electromed in the 4th quarter valued at approximately $99,000. Bank of America Corp DE lifted its stake in Electromed by 179.2% in the 4th quarter. Bank of America Corp DE now owns 4,004 shares of the company's stock valued at $118,000 after acquiring an additional 2,570 shares in the last quarter. Finally, Tower Research Capital LLC TRC boosted its position in Electromed by 426.6% during the 4th quarter. Tower Research Capital LLC TRC now owns 5,055 shares of the company's stock worth $149,000 after acquiring an additional 4,095 shares during the last quarter. Institutional investors and hedge funds own 40.82% of the company's stock.

Electromed Trading Up 0.4%

ELMD stock traded up $0.08 during mid-day trading on Thursday, hitting $20.41. 26,272 shares of the company were exchanged, compared to its average volume of 72,506. Electromed, Inc. has a 1-year low of $13.74 and a 1-year high of $35.56. The stock has a market capitalization of $171.16 million, a PE ratio of 27.21 and a beta of 0.46. The business has a 50 day simple moving average of $22.36 and a 200-day simple moving average of $27.06.

Electromed announced that its Board of Directors has approved a share buyback plan on Monday, March 10th that permits the company to buyback $5.00 million in outstanding shares. This buyback authorization permits the company to buy up to 2.4% of its shares through open market purchases. Shares buyback plans are typically a sign that the company's management believes its stock is undervalued.

Analysts Set New Price Targets

ELMD has been the subject of a number of recent research reports. B. Riley upgraded shares of Electromed to a "strong-buy" rating in a research note on Thursday, May 15th. Wall Street Zen cut Electromed from a "strong-buy" rating to a "buy" rating in a research report on Thursday, May 8th.

About Electromed

Electromed, Inc develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions.